Independent global research organization Frost & Sullivan honored Barco, a healthcare imaging solutions company, with the 2013 North American Product Line Strategy Award in Diagnostic Imaging Displays at the 2013 Growth, Innovation & Leadership Awards on Sept. 9, 2013 in San Jose, Calif. The award recognized Barco for delivering excellence and best practices in the North American diagnostic image displays market.

Fabry disease can be detected using a new magnetic resonance imaging (MRI) technique that was developed at the University of Alberta. The discovery of this new diagnostic tool has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.

Sudden cardiac death (SCD) is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children’s Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems Inc. to conduct The Athlete Heart Research Study. Initial participants included volunteer high school rowers with more than two years of continuous practice who competed in the USRowing Youth National Championships, June 7 – 9, 2013, in Oak Ridge, Tenn.

Methodist Le Bonheur Healthcare (MLH) will deploy McKesson’s portfolio of enterprise medical imaging products across its facilities to improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.